Falcon Therapeutics, Inc.
Biotechnology company · Chapel Hill, North Carolina, United States
Falcon Therapeutics, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $700,000 sold in a notice filed in 2017.
Falcon Therapeutics at a glance
What does Falcon Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.7 million in total (2017 to 2019). NIH funding came from the National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $700,000 sold (2017).
Frequently asked questions about Falcon Therapeutics
Where is Falcon Therapeutics headquartered?
Falcon Therapeutics, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Falcon Therapeutics do?
Falcon Therapeutics, Inc. is a biotechnology company.
When was Falcon Therapeutics founded?
The earliest incorporation on record for Falcon Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- BioKier, Inc.Chapel Hill, North Carolina, United States
- Redbud Labs, Inc.Chapel Hill, North Carolina, United States
- Clinical Tools, IncChapel Hill, North Carolina, United States
- OncoTrap, Inc.Chapel Hill, North Carolina, United States
- Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
- Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Theravida, Inc.Chapel Hill, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences